Search - tctmd.com

Displaying 61 - 80 of 117

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Caitlin E. Cox

January 07, 2019

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

Presentation TCT Abstracts Posters 2018

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Presenter: Pravin Patil

September 25, 2018

News Conference News PCR London Valves 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Shelley Wood

September 12, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Advertisement

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content